Industry Webcast

From Early Signs to Early Action: Diagnosing and Managing Excess Adiposity as a Cardiometabolic Risk DriverIndustry Webcast Sponsored by Eli Lilly & Company; Not for CME/CE Credit

This educational program is designed to help primary care clinicians recognize excess adiposity earlier in the disease continuum and understand its role as a key driver of cardiometabolic risk. Through practical, evidence-based guidance, participants will explore how to identify early clinical signs and obesity-related complications, apply current diagnostic and staging approaches beyond BMI alone, and implement timely interventions to reduce the risk of disease progression. The session will emphasize the importance of early recognition, accurate diagnosis, and proactive management to support improved long-term patient outcomes.